SI21223A - Farmacevtska formulacija s stabiliziranim amorfnim donepezilijevim kloridom - Google Patents

Farmacevtska formulacija s stabiliziranim amorfnim donepezilijevim kloridom Download PDF

Info

Publication number
SI21223A
SI21223A SI200200155A SI200200155A SI21223A SI 21223 A SI21223 A SI 21223A SI 200200155 A SI200200155 A SI 200200155A SI 200200155 A SI200200155 A SI 200200155A SI 21223 A SI21223 A SI 21223A
Authority
SI
Slovenia
Prior art keywords
donepezil
pharmaceutically acceptable
donepezil hydrochloride
pharmaceutical formulation
mixture
Prior art date
Application number
SI200200155A
Other languages
English (en)
Slovenian (sl)
Inventor
Miha Vrbinc
Kolar Ale�A Pun�Uh
Franc Vre�er
Jordan Berta Kotar
Veronika �Tangelj
Original Assignee
Krka, Tovarna Zdravil, D.D., Novo Mesto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka, Tovarna Zdravil, D.D., Novo Mesto filed Critical Krka, Tovarna Zdravil, D.D., Novo Mesto
Priority to SI200200155A priority Critical patent/SI21223A/sl
Priority to UAA200500514A priority patent/UA86573C2/ru
Priority to AU2003279102A priority patent/AU2003279102A1/en
Priority to DK03741747T priority patent/DK1513528T3/da
Priority to ES03741747T priority patent/ES2326529T3/es
Priority to PT03741747T priority patent/PT1513528E/pt
Priority to PL372116A priority patent/PL212584B1/pl
Priority to EP03741747A priority patent/EP1513528B1/en
Priority to SI200331643T priority patent/SI1513528T1/sl
Priority to YU110604A priority patent/RS51824B/en
Priority to AT03741747T priority patent/ATE431739T1/de
Priority to EA200500040A priority patent/EA012904B1/ru
Priority to DE60327696T priority patent/DE60327696D1/de
Priority to PCT/SI2003/000019 priority patent/WO2004000317A1/en
Publication of SI21223A publication Critical patent/SI21223A/sl
Priority to HRP20041198AA priority patent/HRP20041198B1/hr
Priority to CY20091100878T priority patent/CY1109314T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
SI200200155A 2002-06-19 2002-06-19 Farmacevtska formulacija s stabiliziranim amorfnim donepezilijevim kloridom SI21223A (sl)

Priority Applications (16)

Application Number Priority Date Filing Date Title
SI200200155A SI21223A (sl) 2002-06-19 2002-06-19 Farmacevtska formulacija s stabiliziranim amorfnim donepezilijevim kloridom
EP03741747A EP1513528B1 (en) 2002-06-19 2003-06-18 Pharmaceutical composition containing stabilised amorphous form of donepezil hydrochloride
SI200331643T SI1513528T1 (sl) 2002-06-19 2003-06-18 Farmacevtski sestavek, ki vsebuje stabilizirano amorfno obliko donepezilijevega hidroklorida
DK03741747T DK1513528T3 (da) 2002-06-19 2003-06-18 Farmaceutisk sammens tning indeholdende stabiliserede amorfe former af donepezilhydrochlorid
ES03741747T ES2326529T3 (es) 2002-06-19 2003-06-18 Composicion farmaceutica que contiene una forma amorfa estabilizada de clorhidrato de donepezil.
PT03741747T PT1513528E (pt) 2002-06-19 2003-06-18 Composição farmacêutica contendo forma amorfa estabilizada de cloridrato de donepezilo
PL372116A PL212584B1 (pl) 2002-06-19 2003-06-18 Kompozycja farmaceutyczna zawierajaca chlorowodorek donepezilu w bezpostaciowej formie i sposób jej wytwarzania, sposób wytwarzania bezpostaciowej formy chlorowodorku donepezilu i jego zastosowanie
UAA200500514A UA86573C2 (ru) 2002-06-19 2003-06-18 Фармацевтическая композиция, которая содержит стабилизированную аморфную форму донепезила гидрохлорида
AU2003279102A AU2003279102A1 (en) 2002-06-19 2003-06-18 Pharmaceutical composition containing stabilised amorphous form of donepezil hydrochloride
YU110604A RS51824B (en) 2002-06-19 2003-06-18 PHARMACEUTICAL FORMULATION WITH STABILIZED AMORPHIC FORM OF DONEPESIL HYDROCHLORIDE
AT03741747T ATE431739T1 (de) 2002-06-19 2003-06-18 Pharmazeutische zusammensetzung enthaltend stabilisierte amorphe form von donepezil hydrochlorid
EA200500040A EA012904B1 (ru) 2002-06-19 2003-06-18 Фармацевтическая композиция, содержащая стабилизированную аморфную форму донепезил гидрохлорида
DE60327696T DE60327696D1 (de) 2002-06-19 2003-06-18 Pharmazeutische zusammensetzung enthaltend stabilisierte amorphe form von donepezil hydrochlorid
PCT/SI2003/000019 WO2004000317A1 (en) 2002-06-19 2003-06-18 Pharmaceutical composition containing stabilised amorphous form of donepezil hydrochloride
HRP20041198AA HRP20041198B1 (hr) 2002-06-19 2004-12-17 Farmaceutski pripravci koji sadrže stabiliziranu amorfnu formu donepezil hidroklorida
CY20091100878T CY1109314T1 (el) 2002-06-19 2009-08-17 Φαρμακευτικη συνθεση περιεχουσα σταθεροποιημενη αμορφη μορφη της υδροχλωρικης ντονεπεζιλης

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SI200200155A SI21223A (sl) 2002-06-19 2002-06-19 Farmacevtska formulacija s stabiliziranim amorfnim donepezilijevim kloridom

Publications (1)

Publication Number Publication Date
SI21223A true SI21223A (sl) 2003-12-31

Family

ID=29778199

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200200155A SI21223A (sl) 2002-06-19 2002-06-19 Farmacevtska formulacija s stabiliziranim amorfnim donepezilijevim kloridom
SI200331643T SI1513528T1 (sl) 2002-06-19 2003-06-18 Farmacevtski sestavek, ki vsebuje stabilizirano amorfno obliko donepezilijevega hidroklorida

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI200331643T SI1513528T1 (sl) 2002-06-19 2003-06-18 Farmacevtski sestavek, ki vsebuje stabilizirano amorfno obliko donepezilijevega hidroklorida

Country Status (15)

Country Link
EP (1) EP1513528B1 (hr)
AT (1) ATE431739T1 (hr)
AU (1) AU2003279102A1 (hr)
CY (1) CY1109314T1 (hr)
DE (1) DE60327696D1 (hr)
DK (1) DK1513528T3 (hr)
EA (1) EA012904B1 (hr)
ES (1) ES2326529T3 (hr)
HR (1) HRP20041198B1 (hr)
PL (1) PL212584B1 (hr)
PT (1) PT1513528E (hr)
RS (1) RS51824B (hr)
SI (2) SI21223A (hr)
UA (1) UA86573C2 (hr)
WO (1) WO2004000317A1 (hr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL150509A (en) * 2002-07-01 2007-07-04 Joseph Kaspi Pharmaceutical preparations containing donafazil hydrochloride
IL154370A0 (en) * 2003-02-10 2003-09-17 Chemagis Ltd Solid amorphous mixtures, processes for the preparation thereof and pharmaceutical compositions containing the same
US20050232990A1 (en) * 2003-12-31 2005-10-20 Garth Boehm Donepezil formulations
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US7592459B2 (en) 2004-09-29 2009-09-22 Chemagis Ltd. Use of purified donepezil maleate for preparing pharmaceutically pure amorphous donepezil hydrochloride
SI1811957T1 (sl) * 2004-10-19 2009-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Trden farmacevtski sestavek, ki obsega donepezil hidroklorid
WO2006063025A1 (en) * 2004-12-07 2006-06-15 Nektar Therapeutics Stable non-crystalline formulation comprising donepezil
US20060122226A1 (en) 2004-12-08 2006-06-08 Itai Adin Crystalline forms of Donepezil base
EP1830886B1 (en) 2004-12-27 2016-04-13 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
JP2007015934A (ja) * 2005-07-05 2007-01-25 Meiko Shoji Kk 温感クリーム化粧料
DE102005060377A1 (de) 2005-12-16 2007-06-21 Ratiopharm Gmbh Pharmazeutische Zusammensetzung enthaltend Donepezilhydrochlorid, Tablette hieraus und Verfahren zu deren Herstellung
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
DE102007037932A1 (de) 2007-08-11 2009-02-12 Alfred E. Tiefenbacher Gmbh & Co.Kg Donepezilhydrochlorid in amorpher Form enthaltende Tablette
DE102009041839A1 (de) * 2009-09-18 2011-03-24 Dolorgiet Gmbh & Co. Kg Donepezil-haltige Tabletten
EP2366378A1 (en) 2010-03-01 2011-09-21 Dexcel Pharma Technologies Ltd. Sustained-release donepezil formulations
WO2011151359A1 (en) 2010-06-02 2011-12-08 Noscira, S.A. Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
EP2502620A1 (en) 2011-03-24 2012-09-26 Krka Tovarna Zdravil, D.D., Novo Mesto Solid pharmaceutical composition comprising donepezil
EP2825159B1 (en) 2012-03-15 2022-06-22 Boehringer Ingelheim Vetmedica GmbH Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
AU2014292086B2 (en) 2013-07-19 2019-08-08 Boehringer Ingelheim Vetmedica Gmbh Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
EP2925305B1 (en) 2013-12-04 2016-07-27 Boehringer Ingelheim Vetmedica GmbH Improved pharmaceutical compositions of pimobendan
US20180344646A1 (en) * 2015-11-25 2018-12-06 Patheon Development Services Inc. Amorphous dispersion granules and oral dosage forms
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
KR102372630B1 (ko) * 2019-05-15 2022-03-14 주식회사 대웅제약 고함량의 도네페질 또는 그의 염을 포함하는 경피흡수제제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2525108B1 (fr) * 1982-04-19 1989-05-12 Elan Corp Ltd Medicaments a haut degre de solubilite et procede pour leur obtention
CA2252806C (en) * 1996-06-07 2005-11-22 Eisai Co., Ltd. Polymorphs of donepezil hydrochloride and process for production
ES2310164T3 (es) * 1999-02-10 2009-01-01 Pfizer Products Inc. Dispositivo de liberacion controlada por la matriz.
ATE329579T1 (de) * 1999-11-12 2006-07-15 Abbott Lab Feste dispersion mit ritonavir, fenofibrat oder griseofulvin

Also Published As

Publication number Publication date
EP1513528A1 (en) 2005-03-16
CY1109314T1 (el) 2014-07-02
ATE431739T1 (de) 2009-06-15
EP1513528B1 (en) 2009-05-20
WO2004000317A1 (en) 2003-12-31
PL212584B1 (pl) 2012-10-31
EA012904B1 (ru) 2010-02-26
PL372116A1 (en) 2005-07-11
HRP20041198B1 (hr) 2013-05-31
DE60327696D1 (de) 2009-07-02
ES2326529T3 (es) 2009-10-14
UA86573C2 (ru) 2009-05-12
PT1513528E (pt) 2009-08-18
EA200500040A1 (ru) 2005-06-30
AU2003279102A1 (en) 2004-01-06
RS110604A (en) 2007-02-05
DK1513528T3 (da) 2009-09-07
HRP20041198A2 (en) 2005-04-30
RS51824B (en) 2012-02-29
SI1513528T1 (sl) 2009-10-31

Similar Documents

Publication Publication Date Title
SI21223A (sl) Farmacevtska formulacija s stabiliziranim amorfnim donepezilijevim kloridom
US6720003B2 (en) Serotonin reuptake inhibitor formulations
EP2068839B1 (en) Pharmaceutical compositions comprising nilotinib or its salt
ES2334933T3 (es) Comprimido recubierto o granulado que contiene una piridilpirimidina.
JP6498658B2 (ja) 複素環化合物およびその使用
US20100010098A1 (en) Polymorphs of rasagiline hydrochloride
KR102008490B1 (ko) 콜린 알포세레이트 또는 이의 약학적으로 허용되는 염을 포함하는 방출 조절형 약학 조성물 및 이의 제조방법
JPWO2003082279A1 (ja) 単一の結晶形を含有する固形製剤
EP2178507B1 (en) Pharmaceutical composition comprising solifenacin or a pharmaceutically acceptable salt thereof
JP6399115B2 (ja) アンギオテンシンｉｉ拮抗作用を有する化合物を含有する固形医薬組成物
WO2018019300A1 (zh) 一种口服固体制剂及其应用
WO2012140604A1 (en) Stable formulations of pramipexole hydrochloride
JP6737060B2 (ja) イルベサルタンを含有する医薬組成物の製造方法
WO2011101862A1 (en) Stabilized fluconazole polymorph iii formulation
EP2185130B1 (de) Verfahren zur herstellung einer donepezilhydrochlorid in amorpher form enthaltenden tablette
EP2827848B1 (en) Stabilized pharmaceutical compositions comprising rasagiline salts
EP2945948B1 (en) Crystalline form ii of anagrelide hydrochloride monohydrate
EP1567131A1 (en) Bupropion hydrochloride solid dosage forms
EP2803353B1 (en) Compositions of Imatinib
JPWO2004089344A1 (ja) 錠剤の製造方法
JP2023551597A (ja) フタラジノン誘導体を含む薬剤学的組成物
EP4321154A1 (en) A tablet of tolvaptan and at least one binder processed with spray granulation
CZ201039A3 (cs) Zpusob prumyslové výroby amorfní formy hemivápenaté soli (3R,5R) 7-[3-fenyl-4-fenylkarbamoyl-2-(4-fluorfenyl)-5-isopropylpyrrol-1-yl]-3,5-dihydroxyheptanové kyseliny (atorvastatinu) s vysokým specifickým povrchem a jeho použití v lékové forme
KR20060036271A (ko) 안정성이 개선된 암로디핀 말레에이트 약학 조성물
CA2872991A1 (en) Stable oral pharmaceutical composition of solifenacin

Legal Events

Date Code Title Description
IF Valid on the event date
KO00 Lapse of patent

Effective date: 20120704